FSD Pharma Inc. (HUGE): Price and Financial Metrics
HUGE Price/Volume Stats
| Current price | $0.46 | 52-week high | $1.78 |
| Prev. close | $0.50 | 52-week low | $0.42 |
| Day low | $0.42 | Volume | 314,200 |
| Day high | $0.50 | Avg. volume | 129,459 |
| 50-day MA | $0.76 | Dividend yield | N/A |
| 200-day MA | $1.03 | Market Cap | 18.14M |
HUGE Stock Price Chart Interactive Chart >
FSD Pharma Inc. (HUGE) Company Bio
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.
Latest HUGE News From Around the Web
Below are the latest news stories about FSD PHARMA INC that investors may wish to consider to help them evaluate HUGE as an investment opportunity.
FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SECTORONTO, ON / ACCESSWIRE / December 22, 2023 / FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased ... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! |
FSD Pharma Inc. Announces Closing of Private PlacementTORONTO, ON / ACCESSWIRE / December 5, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (the "Company" or "FSD"), is pleased to announce that, further to its news release on November 27, 2023, it has closed a non-brokered private placement ... |
FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of ArrangementTORONTO, ON / ACCESSWIRE / November 30, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company) and Celly Nutrition Corp. ("Celly Nu") are pleased to announce the closing of the previously announced proposed distribution ... |
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter WellnessTORONTO, ON / ACCESSWIRE / November 28, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The Company ... |
HUGE Price Returns
| 1-mo | -36.99% |
| 3-mo | -47.49% |
| 6-mo | -58.56% |
| 1-year | -69.74% |
| 3-year | -71.43% |
| 5-year | -98.69% |
| YTD | -49.99% |
| 2023 | 16.67% |
| 2022 | -22.71% |
| 2021 | -34.62% |
| 2020 | -71.26% |
| 2019 | -87.37% |
Loading social stream, please wait...